Uroxatral (Alfuzosin) – Patient Guide (Australia)
Uroxatral is a medicine containing alfuzosin, used to treat symptoms of benign prostatic hyperplasia (BPH)—also called an enlarged prostate. It works by relaxing smooth muscle in the prostate and bladder neck to help improve urine flow and reduce troublesome urinary symptoms.
This guide explains how Uroxatral works, how it is used, key safety information, common interactions (including food and alcohol), and what to expect in day-to-day use. It is written for patients in Australia and includes practical tips to help you get the best benefit from treatment.
Basic product information
| Item | Details |
|---|---|
| Medicine name | Uroxatral |
| Active ingredient | Alfuzosin |
| Medicine type | Alpha-1 blocker (alpha-adrenergic antagonist) |
| Common purpose | Treat urinary symptoms from BPH (enlarged prostate) |
| Common formulation | Extended-release tablet (designed for once-daily dosing) |
What is Uroxatral used for?
Uroxatral is indicated for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). BPH is common in older men as the prostate enlarges, narrowing the urethra and affecting urine flow.
Symptoms may include:
- Weak urine stream
- Difficulty starting urination
- Frequent urination, including at night
- Urgency (a strong need to urinate)
- Feeling that the bladder hasn’t emptied fully
How Uroxatral works (mechanism of action)
Alfuzosin is an alpha-1 adrenergic receptor antagonist. It blocks alpha-1 receptors located in the smooth muscle of the prostate and the bladder neck. This leads to:
- Relaxation of smooth muscle in the prostate and bladder neck
- Widening of the urinary channel
- Reduced resistance to urine flow
- Improved ability to start urinating and reduced symptoms
Uroxatral helps relieve symptoms, but it does not usually shrink the prostate as dramatically as some other treatments. Many people notice symptom improvement over days to weeks.
Pharmacokinetics (how the body handles alfuzosin)
Pharmacokinetics describes absorption, distribution, metabolism, and elimination.
Absorption and onset
- Uroxatral is formulated to release alfuzosin steadily (extended-release), supporting once-daily use.
- Absorption can be influenced by food, which is why dosing instructions commonly specify taking it with meals.
Distribution
- Alfuzosin is distributed throughout the body, with significant activity in tissues related to urinary tract function.
Metabolism
- Alfuzosin is primarily metabolised by the liver.
- Because of liver metabolism, dose selection and safety precautions are important in people with hepatic impairment.
Elimination
- Excretion occurs mainly through hepatic metabolism and subsequent clearance from the body.
- Kidney impairment may require extra caution, depending on overall health status and specific product guidance.
Typical dosing and timing (how to take it)
Always follow the dosing instructions provided with your medication. Dosage may vary depending on formulation strength and individual factors such as age and liver function.
General dosing approach
- Commonly taken because Uroxatral is an extended-release medicine.
- Often advised to take after the same meal each day (food timing matters—see food section below).
How to take Uroxatral tablets
- Take the tablet whole with a glass of water.
- Do not crush, split, or chew extended-release tablets unless the product instructions specifically allow it.
- Choose a time you can consistently maintain to support stable daily drug levels.
If you miss a dose
- Take your missed dose as soon as you remember if it is still close to your usual time.
- If it’s nearly time for your next dose, skip the missed dose and continue as normal.
- Do not double up.
Seek advice if you are unsure, especially if you miss multiple doses.
Indications and who may benefit
Uroxatral is mainly prescribed for men with BPH-related lower urinary tract symptoms. It may be considered when symptoms affect quality of life, such as:
- Urinary frequency and nocturia (getting up at night to urinate)
- Weak stream or incomplete emptying sensation
- Reduced stream severity impacting daily activities
It may be used alone or alongside other BPH management approaches depending on the situation. Your clinician may consider factors including symptom severity, prostate size, urinary retention risk, and overall cardiovascular health.
Food interactions (important)
For alfuzosin, food can significantly affect absorption and therefore effectiveness. Many patients are advised to take extended-release alfuzosin with food, typically after a meal.
Practical guidance
- Take Uroxatral after a meal (for example, after breakfast or after the evening meal—whichever is consistent for you).
- Try to avoid taking it on an empty stomach unless instructed otherwise by your clinician or the product instructions.
- Maintain a regular meal timing pattern when possible.
If you are switching meal times (e.g., shift work), ask for advice on how to adjust dosing schedule safely.
Alcohol and medicine interactions
Uroxatral can lower blood pressure. Alcohol may also lower blood pressure and can worsen side effects such as dizziness or light-headedness.
Alcohol
- Limit alcohol, especially when starting or increasing the dose.
- Be cautious with driving or operating machinery if you feel dizzy.
Medicine interactions (key categories)
Several medicine classes can increase the risk of low blood pressure or interact with alfuzosin levels.
- Other alpha-blockers: combining may increase risk of dizziness and hypotension.
- CYP3A4 inhibitors (some medicines that affect drug metabolism), such as certain antifungals and some antibiotics: may raise alfuzosin levels.
- Medicines for erectile dysfunction (e.g., PDE5 inhibitors like sildenafil/tadalafil) or other vasodilators: may add to blood pressure-lowering effects.
- Antihypertensives (blood pressure medicines): may increase the likelihood of low blood pressure symptoms.
- Nitrates: can strongly lower blood pressure when combined with other medicines affecting vascular tone.
Always check with your pharmacist if you’re taking multiple medicines, including over-the-counter products and supplements.
Important: Tell your healthcare provider about all medicines you use, including for heart conditions, blood pressure, diabetes, and any medications started recently.
Safety profile and common side effects
Like all medicines, Uroxatral can cause side effects. Not everyone will experience them. Many side effects are related to blood pressure effects (dizziness) because alpha-1 blockers relax blood vessels as well as urinary tract muscles.
Common side effects
- Dizziness or light-headedness
- Headache
- Fatigue
- Nasal congestion or runny nose
- Low blood pressure (sometimes associated with standing up)
Less common but important reactions
- Fainting (syncope), particularly when standing
- Palpitations or changes in heart rate
- Swelling (oedema)
- Allergic-type reactions (rare)
Seek urgent medical help if
- You faint, feel severe dizziness, or have symptoms of dangerously low blood pressure
- You have chest pain or severe palpitations
- You develop signs of an allergic reaction such as facial swelling, rash, or breathing difficulty
Practical safety tips for everyday use
- Be careful when standing: If you feel dizzy, rise slowly from sitting or lying positions.
- First days matter: Dizziness and low blood pressure are more likely when starting therapy or restarting after a break.
- Know your triggers: Dehydration, heat exposure, and alcohol can worsen dizziness.
- Hydration: Maintain adequate fluid intake unless you’ve been advised to restrict fluids for another medical reason.
- Driving and machinery: Use caution until you know how Uroxatral affects you.
- Falls prevention: If you’re at risk of falls, consider extra support at the times you take your dose.
Eye-related precaution (important for cataract surgery): Alpha-1 blockers, including alfuzosin, have been associated with a condition called Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery. If you are planning cataract surgery, inform your eye surgeon and ophthalmology team that you take Uroxatral.
Dosing considerations (who needs extra caution)
Some people may require additional monitoring or alternative dosing strategies.
Older adults
- Older adults may be more sensitive to dizziness and low blood pressure.
- Extra caution is recommended when starting therapy.
Liver impairment
- Because alfuzosin is metabolised by the liver, hepatic impairment can increase drug exposure.
- There may be contraindications or restrictions—follow the product guidance and clinician advice.
Heart and blood pressure conditions
- If you have existing low blood pressure, fainting episodes, or certain heart conditions, your clinician may monitor you more closely.
- Because Uroxatral can lower blood pressure, careful review of your cardiovascular medicines is important.
Urinary retention or severe obstruction
- Uroxatral improves symptoms in many people, but severe urinary retention or complicated urinary obstruction may require urgent evaluation.
- If you cannot urinate, seek urgent medical care.
When can you expect symptom improvement?
Many patients notice changes in urinary symptoms within days, though full benefit may take a few weeks depending on the individual and symptom severity. If you don’t experience improvement or symptoms worsen after starting, speak with a pharmacist or clinician for review.
Do not stop or change the dose without advice—urinary symptoms may return.
Alternative treatment options for BPH
BPH management may include medication and lifestyle strategies. Alternatives depend on symptom pattern, severity, and prostate size.
Other medicine options
- Other alpha-1 blockers: e.g., tamsulosin, doxazosin, terazosin (choices depend on side effect profiles and individual factors).
- 5-alpha-reductase inhibitors: e.g., finasteride or dutasteride—may reduce prostate size over time.
- Combination therapy: alpha-blocker plus 5-alpha-reductase inhibitor in selected patients.
- Other approaches: in certain cases, antimuscarinic or beta-3 agonist therapies may address overactive bladder components.
Non-medicine options
- Fluid management (especially in the evening)
- Reducing caffeine and alcohol if they worsen symptoms
- Timed voiding
- Weight and activity adjustments
- Procedural or surgical options if symptoms are severe or complications occur
A pharmacist can help you understand what alternatives might be appropriate to discuss with your clinician.
Market and legal context for Australia
In Australia, medicines are regulated through the Therapeutic Goods Administration (TGA). Availability and classification (e.g., prescription-only status) depend on the specific product and safety evaluation.
Uroxatral contains an active medicine that is commonly managed under Australia’s medicines regulatory framework. Online pharmacy suppliers should ensure products are sourced from authorised channels and meet Australian quality standards.
Important: Always buy from reputable Australian pharmacy websites. Check that the listing includes the active ingredient, strength/formulation, and clear product details.
Recent guidance: International and Australian BPH guidance continues to emphasise individualised symptom assessment, blood pressure and fall risk review, and careful medication interaction checks—especially with alpha-blockers. Ongoing focus includes safe use around surgery (e.g., cataract surgery precautions) and monitoring for hypotension-related symptoms.
Delivery and availability (online pharmacy in Australia)
Online pharmacies in Australia typically offer:
- Home delivery within metropolitan and regional areas (delivery times vary)
- Tracking for dispatched orders where available
- Packaging designed to protect tablets during transport
Availability can vary based on local stock levels. If Uroxatral isn’t immediately available, many pharmacies can offer:
- Expected restock timelines
- Similar therapeutic options (where appropriate) for discussion with a clinician
- Substitution policies aligned with Australian pharmacy practice
Storage: Keep tablets in the original packaging and store below 30°C unless the label instructs otherwise. Protect from moisture and heat.
FAQ – Uroxatral (Alfuzosin)
1) Is Uroxatral a painkiller or an antibiotic?
No. Uroxatral is an alpha-1 blocker used for urinary symptoms caused by BPH. It is not an antibiotic and not used to treat infections directly.
2) How long does it take to work?
Some people notice symptom improvement within days. For others, meaningful improvement may take a few weeks. Consistent daily use and taking it with meals as directed support effectiveness.
3) Should I take it with food?
Uroxatral extended-release dosing is commonly advised after meals because food can improve absorption and reduce variability. Follow the instructions provided with your product.
4) Can I drink alcohol while taking Uroxatral?
Alcohol can increase dizziness and the risk of low blood pressure. It’s best to limit alcohol, especially when starting treatment or if you feel light-headed.
5) What should I do if I feel dizzy after taking a dose?
Sit or lie down immediately if you feel faint. Rise slowly later. Avoid driving if you feel unsteady. Contact a pharmacist or clinician promptly—especially if symptoms persist or you faint.
6) Can Uroxatral affect blood pressure?
Yes. Because alfuzosin can relax blood vessels, some people experience low blood pressure. This is one reason dizziness and fainting risk is higher at the start of therapy.
7) Are there medicines I must avoid?
Certain drugs can increase alfuzosin exposure or increase the chance of low blood pressure, including some antifungals, certain antibiotics, and medicines for erectile dysfunction or blood pressure. Always check interactions with a pharmacist.
8) What about cataract surgery?
If you take alfuzosin, tell your eye surgeon before cataract surgery. Alpha-1 blockers are associated with IFIS during surgery, and your surgical team can take precautions.
9) What if I stop taking it?
Stopping Uroxatral may cause urinary symptoms to return. If you’re considering stopping, talk to a pharmacist or clinician first.
10) Is Uroxatral suitable for everyone with urinary symptoms?
No. Symptoms can also be caused by other conditions such as urinary tract infection, bladder issues, or prostate cancer. If you have blood in urine, severe pain, fever, inability to urinate, or rapidly worsening symptoms, seek prompt medical assessment.
Key takeaways
- Uroxatral (alfuzosin) helps relieve BPH urinary symptoms by relaxing smooth muscle in the prostate and bladder neck.
- Take it consistently and often with meals as instructed—food can influence absorption.
- Be cautious of dizziness or low blood pressure, especially when starting or if you drink alcohol.
- Inform healthcare providers (including your eye surgeon) about alfuzosin use.
- If you have severe symptoms such as inability to urinate, seek urgent medical care.
Need help choosing the right option? If you’d like, share your current medicines and any past history of low blood pressure or dizziness with a pharmacist. They can help you check for likely interactions and safe use.

